FDA Safety Alert - Zithromax (azithromycin): Risk of Cardiovascular Death

Fri, 18 May 2012 07:21:00 GMT

FDA is reviewing the results from a New England Journal of Medicine study reporting a small increase in cardiovascular deaths, in persons treated with a 5-day course of azithromycin

FDA News - Generic Versions of Plavix Approved

Fri, 18 May 2012 07:13:00 GMT

FDA approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate), which helps reduce the risk of heart attack and stroke

FDA Safety Alert - Tekturna

Mon, 23 Apr 2012 14:42:00 GMT

New Warning and Contraindication for blood pressure medicines containing aliskiren

FDA Safety Alert - Fentanyl Patches

Mon, 23 Apr 2012 12:45:00 GMT

FDA Reminds the Public about the Potential for Life-Threatening Harm from Accidental Exposure to Fentanyl Transdermal Systems (“Patches”)

FDA Safety Alert - Revised Recommendations for Celexa

Thu, 29 Mar 2012 09:47:00 GMT

related to a potential risk of abnormal heart rhythms with high doses

FDA Safety Alert - Label Changes to Cholesterol-lowering Statin Drugs

Tue, 28 Feb 2012 15:49:00 GMT

Changes were made to the labels to provide the public with more information for the safe and effective use of statins.

Healthe Marketing Wins 3 Local ADDY Awards

Tue, 28 Feb 2012 12:15:00 GMT

Awards include a Silver ADDY for Interactive Media, a Gold Core Creative ADDY for Collateral Material and a Silver Core Creative ADDY for Interactive Media.

Voltaren gel 1% (Diclofenac Sodium Topical Gel) Shortage

Thu, 16 Feb 2012 15:45:00 GMT

This temporary shortage is not related to the efficacy or safety of Voltaren Gel.

FDA Safety Alert - Recall of Excedrin, NoDoz, Bufferin, Gas-X Prevention

Mon, 09 Jan 2012 14:59:00 GMT

Novartis Consumer Health Over-The-Counter Products: Recall - Potential Presence of Foreign Tablets or Chipped or Broken Tablets or Gelcaps

FDA Drug Safety Info - Certain Opiate Products Made for Endo Pharmaceuticals

Sun, 08 Jan 2012 15:48:00 GMT

FDA advises of potential safety risk associated with certain opiate products manufactured for Endo Pharmaceuticals by Novartis Consumer Health.

FDA Drug Info - FDA approves a class Risk Evaluation and Mitigation Strategy (REMS)

Tue, 03 Jan 2012 14:48:00 GMT

for transmucosal immediate-release fentanyl (TIRF) medicines

FDA Alert - Safety Announcement - Multaq

Tue, 20 Dec 2011 09:56:00 GMT

Review update of Multaq (dronedarone) and increased risk of death and serious cardiovascular adverse events

Press Release - Healthe Releases Major Enhancement to State Reporting Tool

Thu, 15 Dec 2011 11:42:00 GMT

Enhancement includes the capability of reporting ancillary benefit management services, such as DME and home health services.

FDA News - FDA approves first generic version of Lipitor

Fri, 02 Dec 2011 08:12:00 GMT

(atorvastatin calcium tablets)

Watson Launches Generic Kadian

Tue, 22 Nov 2011 09:31:00 GMT

Watson Pharmaceuticals Inc. announced FDA approval for its Abbreviated New Drug Application for morphine sulfate ER capsules USP

Press Release - Healthe CEO Ron Roma National Finalist for Ernst & Young Entrepreneur of the Year® 2011

Thu, 17 Nov 2011 10:09:00 GMT

Mr. Roma placed in the top four out of 29 national finalist in the service category.

FDA Alert - Review update of Trilipix & ACCORD Lipid trial

Fri, 11 Nov 2011 09:36:00 GMT

FDA warns that that the cholesterol-lowering medicine Trilipix (fenofibric acid) may not lower a patient's risk of having a heart attack or stroke.

NIH Study - Painkiller abuse treated by sustained buprenorphine/naloxone

Wed, 09 Nov 2011 09:45:00 GMT

NIH announces results from first large scale study on treatment of prescription opioid addiction

CDC Press Release - Prescription painkiller overdoses at epidemic levels

Tue, 01 Nov 2011 10:02:00 GMT

Kill more Americans than heroin and cocaine combined

Press Release - Healthesystems Sponsors Kids' Chance of America

Thu, 27 Oct 2011 12:22:00 GMT

Visit Kids' Chance in booth #658 at the NWCD conference and Healthesystems in booth #901

Featured Articles